![Rudolf Maag](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rudolf Maag
No open positions remaining
Net worth: 4 659 M $ as of 2026-05-30
Profile
Rudolf Maag served as the Chairman of Straumann Holding AG from 2002 to 2010.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAT GROUP AG 10% | 2025-12-30 | 3,000,570 ( 10% ) | 2 346 M $ | 2026-05-30 |
STRAUMANN HOLDING AG 10.2% | 2025-12-30 | 16,264,434 ( 10.2% ) | 1 972 M $ | 2026-05-30 |
LANDIS+GYR GROUP AG 10.38% | 2025-03-30 | 3,000,000 ( 10.38% ) | 194 M $ | 2026-05-30 |
POLYPEPTIDE GROUP AG 3.32% | 2025-12-30 | 1,100,000 ( 3.32% ) | 53 M $ | 2026-05-30 |
IDORSIA LTD. 3.52% | 2024-12-30 | 8,984,333 ( 3.52% ) | 51 M $ | 2026-05-30 |
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases 11.79% | 2026-02-28 | 11,999,999 ( 11.79% ) | 32 M $ | 2026-05-30 |
MIKRON HOLDING AG 2.99% | 2025-04-23 | 499,711 ( 2.99% ) | 11 M $ | 2026-05-30 |
Former positions of Rudolf Maag
| Companies | Position | End |
|---|---|---|
| STRAUMANN HOLDING AG | Chairman | 2010-02-28 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Straumann Holding AG
 Straumann Holding AG Medical SpecialtiesHealth Technology Develops, produces and markets products for dental implants and biomaterials for soft and hard tissue generation | Health Technology |
- Stock Market
- Insiders
- Rudolf Maag
